312 related articles for article (PubMed ID: 35929515)
21. The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: Bile salts as ligands for nuclear hormone receptors.
Redinger RN
Can J Gastroenterol; 2003 Apr; 17(4):265-71. PubMed ID: 12704471
[TBL] [Abstract][Full Text] [Related]
22. Pleiotropic functions of bile acids mediated by the farnesoid X receptor.
Stanimirov B; Stankov K; Mikov M
Acta Gastroenterol Belg; 2012 Dec; 75(4):389-98. PubMed ID: 23402081
[TBL] [Abstract][Full Text] [Related]
23. Alcohol triggered bile acid disequilibrium by suppressing BSEP to sustain hepatocellular carcinoma progression.
Chen W; Zhang Q; Ding M; Yao J; Guo Y; Yan W; Yu S; Shen Q; Huang M; Zheng Y; Lin Y; Wang Y; Liu Z; Lu L
Chem Biol Interact; 2022 Apr; 356():109847. PubMed ID: 35149083
[TBL] [Abstract][Full Text] [Related]
24. Lactoferrin promotes bile acid metabolism and reduces hepatic cholesterol deposition by inhibiting the farnesoid X receptor (FXR)-mediated enterohepatic axis.
Ling CJ; Xu JY; Li YH; Tong X; Yang HH; Yang J; Yuan LX; Qin LQ
Food Funct; 2019 Nov; 10(11):7299-7307. PubMed ID: 31626262
[TBL] [Abstract][Full Text] [Related]
25. Diurnal variations of mouse plasma and hepatic bile acid concentrations as well as expression of biosynthetic enzymes and transporters.
Zhang YK; Guo GL; Klaassen CD
PLoS One; 2011 Feb; 6(2):e16683. PubMed ID: 21346810
[TBL] [Abstract][Full Text] [Related]
26. The potential influence of genetic variants in genes along bile acid and bile metabolic pathway on blood cholesterol levels in the population.
Lu Y; Feskens EJ; Boer JM; Müller M
Atherosclerosis; 2010 May; 210(1):14-27. PubMed ID: 19932478
[TBL] [Abstract][Full Text] [Related]
27. Molecular Basis of Bile Acid-FXR-FGF15/19 Signaling Axis.
Katafuchi T; Makishima M
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682726
[TBL] [Abstract][Full Text] [Related]
28. Bile acids via FXR initiate the expression of major transporters involved in the enterohepatic circulation of bile acids in newborn mice.
Cui JY; Aleksunes LM; Tanaka Y; Fu ZD; Guo Y; Guo GL; Lu H; Zhong XB; Klaassen CD
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G979-96. PubMed ID: 22268101
[TBL] [Abstract][Full Text] [Related]
29. Polygonum multiflorum Thunb suppress bile acid synthesis by activating Fxr-Fgf15 signaling in the intestine.
Wei J; Chen J; Fu L; Han L; Gao X; Sarhene M; Hu L; Zhang Y; Fan G
J Ethnopharmacol; 2019 May; 235():472-480. PubMed ID: 30528660
[TBL] [Abstract][Full Text] [Related]
30. Atorvastatin induces bile acid-synthetic enzyme Cyp7a1 by suppressing FXR signaling in both liver and intestine in mice.
Fu ZD; Cui JY; Klaassen CD
J Lipid Res; 2014 Dec; 55(12):2576-86. PubMed ID: 25278499
[TBL] [Abstract][Full Text] [Related]
31. Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein.
Kok T; Hulzebos CV; Wolters H; Havinga R; Agellon LB; Stellaard F; Shan B; Schwarz M; Kuipers F
J Biol Chem; 2003 Oct; 278(43):41930-7. PubMed ID: 12917447
[TBL] [Abstract][Full Text] [Related]
32. Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma.
Stepien M; Lopez-Nogueroles M; Lahoz A; Kühn T; Perlemuter G; Voican C; Ciocan D; Boutron-Ruault MC; Jansen E; Viallon V; Leitzmann M; Tjønneland A; Severi G; Mancini FR; Dong C; Kaaks R; Fortner RT; Bergmann MM; Boeing H; Trichopoulou A; Karakatsani A; Peppa E; Palli D; Krogh V; Tumino R; Sacerdote C; Panico S; Bueno-de-Mesquita HB; Skeie G; Merino S; Ros RZ; Sánchez MJ; Amiano P; Huerta JM; Barricarte A; Sjöberg K; Ohlsson B; Nyström H; Werner M; Perez-Cornago A; Schmidt JA; Freisling H; Scalbert A; Weiderpass E; Christakoudi S; Gunter MJ; Jenab M
Int J Cancer; 2022 Apr; 150(8):1255-1268. PubMed ID: 34843121
[TBL] [Abstract][Full Text] [Related]
33. Farnesoid X Receptor Activation Enhances Transforming Growth Factor β-Induced Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
Kainuma M; Takada I; Makishima M; Sano K
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29958417
[TBL] [Abstract][Full Text] [Related]
34. Bile Acids Transporters of Enterohepatic Circulation for Targeted Drug Delivery.
Durník R; Šindlerová L; Babica P; Jurček O
Molecules; 2022 May; 27(9):. PubMed ID: 35566302
[TBL] [Abstract][Full Text] [Related]
35. Increased levels of typically fetal bile acid species in patients with hepatocellular carcinoma.
El-Mir MY; Badia MD; Luengo N; Monte MJ; Marin JJ
Clin Sci (Lond); 2001 May; 100(5):499-508. PubMed ID: 11294690
[TBL] [Abstract][Full Text] [Related]
36. FXR signaling in the enterohepatic system.
Matsubara T; Li F; Gonzalez FJ
Mol Cell Endocrinol; 2013 Apr; 368(1-2):17-29. PubMed ID: 22609541
[TBL] [Abstract][Full Text] [Related]
37. Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma.
Chen Y; Song X; Valanejad L; Vasilenko A; More V; Qiu X; Chen W; Lai Y; Slitt A; Stoner M; Yan B; Deng R
Hepatology; 2013 Apr; 57(4):1530-41. PubMed ID: 23213087
[TBL] [Abstract][Full Text] [Related]
38. Dynamics of the enterohepatic circulation of bile acids in healthy humans.
Stellaard F; Lütjohann D
Am J Physiol Gastrointest Liver Physiol; 2021 Jul; 321(1):G55-G66. PubMed ID: 33978477
[TBL] [Abstract][Full Text] [Related]
39. Dihydroartemisinin promoted FXR expression independent of YAP1 in hepatocellular carcinoma.
Guo Y; Peng Q; Hao L; Ji J; Zhang Z; Xue Y; Liu Y; Gao Y; Li C; Shi X
FASEB J; 2022 Jun; 36(6):e22361. PubMed ID: 35616366
[TBL] [Abstract][Full Text] [Related]
40. Role of the enterohepatic circulation of bile salts in lipoprotein metabolism.
Cooper AD
Gastroenterol Clin North Am; 1999 Mar; 28(1):211-29, viii. PubMed ID: 10198786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
